Breaking News Instant updates and real-time market news.

PANW

Palo Alto Networks

$161.06

-0.29 (-0.18%)

08:25
11/22/16
11/22
08:25
11/22/16
08:25

Palo Alto Networks technology still 'best-in-class,' says Maxim

Maxim analyst Nehal Chokshi blames Palo Alto Networks' Q1 revenue miss and softer Q2 guidance to an extension in its large deal sales cycle. However, despite seeing limited upside for the remainder of FY17, he continues to believe that Palo Alto has a best-in-class network security capability and keeps a Buy rating and $185 price target on the shares.

  • 08

    Dec

  • 08

    Dec

PANW Palo Alto Networks
$161.06

-0.29 (-0.18%)

11/22/16
UBSW
11/22/16
NO CHANGE
Target $160
UBSW
Buy
Palo Alto Networks missed but conviction remains, says UBS
UBS analyst Brent Thill noted Palo Alto Networks missed Q1 estimates and that investors are likely to be skeptical about the company's prospects, especially with lighter Q2 guidance. Thill said he is sticking with the name as management has conviction there will be an acceleration in the second half of the year. Thill maintained his Buy rating and lowered his price target to $160 from $165 on Palo Alto Networks shares.
11/22/16
OPCO
11/22/16
NO CHANGE
Target $184
OPCO
Outperform
Oppenheimer remains confident in Palo Alto Networks leadership position
Oppenheimer analyst Shaul Eyal says that while Palo Alto Networks' mixed results were "somewhat disappointing", he remains confident in its leadership position and ability to expand its platform. The analyst is "not losing sight of overall opportunity" as the company morphs into a platform provider and says the dip could provide an attractive buying opportunity. He reiterates an Outperform rating and $184 price target on the shares.
11/22/16
JPMS
11/22/16
NO CHANGE
Target $170
JPMS
Overweight
Palo Alto Networks price target lowered to $170 from $196 at JPMorgan
JPMorgan analyst Sterling Auty lowered his price target for Palo Alto Networks to $170 after the company reported its second-ever revenue miss. Deal slippage on elongated sales cycles in the enterprise led to a shortfall in billings/revenue, Auty tells investors in a post-earnings research note. The miss makes the year more back-end loaded and will likely have investors questioning the company's ability to hit the 12%-13% product revenue growth guidance that was maintained for FY17, the analyst contends. Auty lowered his estimate for product growth down to 11% and keeps an Overweight rating on Palo Alto shares.
11/22/16
PIPR
11/22/16
NO CHANGE
Target $178
PIPR
Overweight
Palo Alto Networks still posting 31% revenue growth, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski points out that despite the "disappointing" Q1 results, Palo Alto Networks (PANW) is still generating 31% revenue growth, which is three-times above closest competitor Cisco (CSCO). He recommends investors hold the stock through the selling pressure. Nowinski lowered his price target for Palo Alto shares to $178 from $184 and keeps an Overweight rating on the name.

TODAY'S FREE FLY STORIES

GRPN

Groupon

$4.53

0.14 (3.19%)

06:05
09/22/17
09/22
06:05
09/22/17
06:05
Initiation
Groupon initiated  »

Groupon initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ECOM

ChannelAdvisor

06:04
09/22/17
09/22
06:04
09/22/17
06:04
Initiation
ChannelAdvisor initiated  »

ChannelAdvisor initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 03

    Oct

  • 04

    Oct

PG

Procter & Gamble

$92.64

-1.76 (-1.86%)

06:04
09/22/17
09/22
06:04
09/22/17
06:04
Hot Stocks
Trian identifies numerous errors in recent Procter & Gamble presentation »

Trian Fund, whose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHUBA

CommerceHub

$23.42

-0.06 (-0.26%)

06:04
09/22/17
09/22
06:04
09/22/17
06:04
Initiation
CommerceHub initiated  »

CommerceHub initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

EVLV

Evine Live

$1.03

0.01 (0.98%)

06:02
09/22/17
09/22
06:02
09/22/17
06:02
Initiation
Evine Live initiated  »

Evine Live initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 16

    Nov

AMZN

Amazon.com

$964.65

-8.56 (-0.88%)

06:01
09/22/17
09/22
06:01
09/22/17
06:01
Hot Stocks
Amazon to add 359,000 square foot office in New York City »

Governor Andrew M. Cuomo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

ICPT

Intercept

$73.70

-24.42 (-24.89%)

06:01
09/22/17
09/22
06:01
09/22/17
06:01
Downgrade
Intercept rating change  »

Wells yesterday…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$171.11

-1.06 (-0.62%)

05:55
09/22/17
09/22
05:55
09/22/17
05:55
Hot Stocks
Instagram adds Face Filters to live video, to roll out globally »

Instagram says in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

PSTG

Pure Storage

$15.02

0.19 (1.28%)

05:55
09/22/17
09/22
05:55
09/22/17
05:55
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

AABA

Altaba

$66.59

-0.33 (-0.49%)

, BABA

Alibaba

$177.39

-0.56 (-0.31%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Recommendations
Altaba, Alibaba, Yahoo Japan analyst commentary  »

Altaba price target…

AABA

Altaba

$66.59

-0.33 (-0.49%)

BABA

Alibaba

$177.39

-0.56 (-0.31%)

YAHOY

Yahoo Japan

$8.90

-0.08 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

REPYY

Repsol

$18.47

0.1 (0.54%)

05:52
09/22/17
09/22
05:52
09/22/17
05:52
Upgrade
Repsol rating change  »

Repsol upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:49
09/22/17
09/22
05:49
09/22/17
05:49
Downgrade
Versartis rating change  »

Versartis downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRPIF

BRP Inc.

05:48
09/22/17
09/22
05:48
09/22/17
05:48
Upgrade
BRP Inc. rating change  »

BRP Inc. upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$92.64

-1.76 (-1.86%)

05:47
09/22/17
09/22
05:47
09/22/17
05:47
Hot Stocks
Glass Lewis recommends Procter & Gamble holders vote for Nelson Peltz »

Trian Fund Management,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$12.27

-0.07 (-0.57%)

05:46
09/22/17
09/22
05:46
09/22/17
05:46
Recommendations
MiMedx analyst commentary  »

MiMedx shares offer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

BA

Boeing

$256.04

0.58 (0.23%)

05:45
09/22/17
09/22
05:45
09/22/17
05:45
Hot Stocks
Boeing sees growing demand for new airplanes in Southeast Asia »

Boeing projects a demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

05:45
09/22/17
09/22
05:45
09/22/17
05:45
General news
Breaking General news story  »

San Francisco Federal…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

, ITRI

Itron

$75.85

-0.4 (-0.52%)

05:40
09/22/17
09/22
05:40
09/22/17
05:40
Downgrade
Silver Spring, Itron rating change  »

Silver Spring downgraded…

SSNI

Silver Spring

$16.15

0.01 (0.06%)

ITRI

Itron

$75.85

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$41.62

-3.59 (-7.94%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Syndicate
Juno Therapeutics 6.1M share Secondary priced at $41.00 »

Morgan Stanley and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 22

    Sep

AA

Alcoa

$46.25

-1.25 (-2.63%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Alcoa rating change  »

Alcoa downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

, POST

Post Holdings

$86.97

-0.39 (-0.45%)

05:38
09/22/17
09/22
05:38
09/22/17
05:38
Downgrade
Bob Evans, Post Holdings rating change  »

Bob Evans downgraded to…

BOBE

Bob Evans

$77.29

-0.2 (-0.26%)

POST

Post Holdings

$86.97

-0.39 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$153.39

-2.68 (-1.72%)

05:36
09/22/17
09/22
05:36
09/22/17
05:36
Recommendations
Apple analyst commentary  »

Piper ups Apple target to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

TIF

Tiffany

$89.85

-0.08 (-0.09%)

05:31
09/22/17
09/22
05:31
09/22/17
05:31
Downgrade
Tiffany rating change  »

Tiffany downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

, VSAR

Versartis

$21.60

-0.25 (-1.14%)

05:27
09/22/17
09/22
05:27
09/22/17
05:27
Recommendations
Ascendis Pharma, Versartis analyst commentary  »

Versartis failure bodes…

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

, BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

05:20
09/22/17
09/22
05:20
09/22/17
05:20
Initiation
Becton Dickinson, C.R. Bard initiated  »

Becton Dickinson…

BDX

Becton Dickinson

$191.56

-2.44 (-1.26%)

BCR

C.R. Bard

$317.37

-1.19 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.